Inserm Transfert, founded in 2000, is the private subsidiary of Inserm, specialized in life sciences technology transfer and collaborative research projects funding. It works under a Public Service Concession Agreement (CSP).
patent families*
number of contracts and licenses*
* For the year 2024
millions of euros invested in Proof of concept
projects detected*
Serving research
The company supports Inserm research units and researchers in the process undertaken to create value from their work. Its actions are part of the translational continuum, from basic and technological research to clinical development, with the aim of creating economic and societal value.
25 ans d'Inserm Transfert : un moment inoubliable pour célébrer l'innovation !
Journées scientifiques de l'ANRS MIE - 1er et 2 avril 2026
La Cité internationale universitaire de Paris accueillera cet évènement majeur consacré cette année au thème : « l’innovation pour accélérer la réponse aux maladies infectieuses ». Le 1er avril Pascale Augé, Présidente du Directoire ...
30/03/2026You are